Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Vimian Group AB ( (SE:VIMIAN) ) has shared an announcement.
Vimian Group AB announced the immediate resignation of CEO Patrik Eriksson, with CFO Carl-Johan Zetterberg Boudrie stepping in as interim CEO. The company is initiating a search for a new CEO to drive its strategic focus on profitable growth and leveraging its global scale. The changes are part of Vimian’s efforts to strengthen its leadership and continue its growth trajectory in the animal health industry.
The most recent analyst rating on (SE:VIMIAN) stock is a Buy with a SEK55.00 price target. To see the full list of analyst forecasts on Vimian Group AB stock, see the SE:VIMIAN Stock Forecast page.
More about Vimian Group AB
Vimian is a global animal health company based in Stockholm, Sweden, operating in four key areas: Specialty Pharma, MedTech, Veterinary Services, and Diagnostics. The company serves over 17,000 veterinary clinics and laboratories across more than 80 markets, employing 1,200 people with annual revenues of approximately EUR 375 million.
Average Trading Volume: 437,380
Current Market Cap: SEK22.53B
Find detailed analytics on VIMIAN stock on TipRanks’ Stock Analysis page.